nach oben

Current Gastroenterology Reports

Erschienen in:

01.04.2011

Biliary Disease in Children

verfasst von: Matthew Goldman, Thomas Pranikoff

Erschienen in: Current Gastroenterology Reports | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Biliary diseases in children are infrequent; however, they can be associated with high morbidity and mortality if an accurate diagnosis is not made and adequate treatment provided in a timely fashion. Biliary atresia, choledochal cysts, gallbladder disease, and Alagille syndrome can be associated with similar clinical symptoms, laboratory findings, and radiographic findings, which makes accurate diagnosis difficult. The correct treatment for each of these clinical entities is different and can significantly reduce morbidity and mortality from these diseases. In this article, we discuss the epidemiology, approach to diagnosis, prognosis, and treatment modalities for these four disease processes.

McEvoy CF, Suchy FJ: Biliary tract disease in children. Pediatr. Clin. North Am. 1996;43(1):75–98.CrossRefPubMed

Ashcraft KW, Holcomb GW, Murphy JP: Pediatric Surgery. Edited by Holcomb GW. 4th ed. Saunders; 2004.

•• Makin E, Quaglia A, Kvist N, et al.: Congenital biliary atresia: liver injury begins at birth. J. Pediatr. Surg. 2009;44(3):630–633. In this retrospective study, patients who were diagnosed with biliary atresia during infancy were evaluated for the timing of liver injury in biliary atresia. Three infants studied had undergone surgical intervention for other presumed diagnoses with concomitant liver biopsies. Diagnosis of biliary atresia was later confirmed in each of these infants, although their liver biopsies within the first week of life were histologically normal. CrossRefPubMed

Bezerra JA: Biliary atresia–translational research on key molecular processes regulating biliary injury and obstruction. Chang Gung Med J. 2006;29(3):222–230.PubMed

Hays DM, Snyder WH: Life-span in untreated biliary atresia. Surgery. 1963;54:373–375.PubMed

Chang M: Screening for biliary atresia. Chang Gung Med J. 2006;29(3):231–233.PubMed

•• Lee WS, Chai PF: Clinical features differentiating biliary atresia from other causes of neonatal cholestasis. Ann. Acad. Med. Singap. 2010;39(8):648–654. In this prospective trial from Malaysia from 1994 to 2004, the authors attempted to find clinical features that help to differentiate biliary atresia from other causes of neonatal cholestasis in 146 patients who presented with jaundice in the first 4 months of life. They found no specific clinical features with adequate sensitivity or specificity to differentiate biliary atresia from many other causes of neonatal cholestasis. PubMed

Kelly DA, Stanton A: Jaundice in babies: implications for community screening for biliary atresia. BMJ. 1995;310(6988):1172–1173.PubMed

Matsui A, Ishikawa T: Identification of infants with biliary atresia in Japan. Lancet. 1994;343(8902):925.CrossRefPubMed

10.

Rozel C, Garel L, Rypens F, et al.: Imaging of biliary disorders in children. Pediatr Radiol. 2010.

11.

Lee H, Lee S, Park W, Choi S: Objective criteria of triangular cord sign in biliary atresia on US scans. Radiology. 2003;229(2):395–400.CrossRefPubMed

12.

•• Raval MV, Dzakovic A, Bentrem DJ, et al.: Trends in age for hepatoportoenterostomy in the United States. Surgery. 2010;148(4):785–791; discussion 791–792. This retrospective study evaluated the age (in days) at which 192 patients underwent Kasai hepatoportoenterostomy for biliary atresia. It showed that, although early operative intervention is associated with better outcomes, the age at operation has not improved over the past two decades. The investigators showed that the age at operation is significantly better at larger institutions, and noted that socioeconomic factors play a role in diagnosis and early treatment. CrossRefPubMed

13.

Haber BA, Erlichman J, Loomes KM: Recent advances in biliary atresia: prospects for novel therapies. Expert Opin Investig Drugs. 2008;17(12):1911–1924.CrossRefPubMed

14.

Shneider BL, Brown MB, Haber B, et al.: A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J. Pediatr. 2006;148(4):467–474.CrossRefPubMed

15.

•• Shinkai M, Ohhama Y, Take H, et al.: Long-term outcome of children with biliary atresia who were not transplanted after the Kasai operation: >20-year experience at a children's hospital. J. Pediatr. Gastroenterol. Nutr. 2009;48(4):443–450. This retrospective chart review examined 80 patients who received surgical intervention for biliary atresia from 1970 to 1986. The study focused on long-term outcomes in those patients who did not subsequently require liver transplantation. It reveals that age at surgery and postoperative bilirubin are associated with development of liver failure. Several of the long-term medical comorbidities in patients 20 years after undergoing surgical intervention are discussed. CrossRefPubMed

16.

Chung HY, Kak Yuen Wong K, Cheun Leung Lan L, Kwong Hang Tam P: Evaluation of a standardized protocol in the use of steroids after Kasai operation. Pediatr. Surg. Int. 2008;24(9):1001–1004.CrossRefPubMed

17.

Davenport M, Stringer MD, Tizzard SA, et al.: Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology. 2007;46(6):1821–1827.CrossRefPubMed

18.

•• Lao OB, Larison C, Garrison M, et al.: Steroid use after the Kasai procedure for biliary atresia. Am. J. Surg. 2010;199(5):680–684. This study examined 516 children at 42 institutions from 2003 to 2008 who underwent surgical intervention for biliary atresia, and studied outcomes of those who received perioperative steroids versus those who did not. Although this study was not able to find statistically significant reductions in cholangitis and mortality, it showed that steroids in the perioperative setting are associated with shorter hospital stay postoperatively. As mentioned above, the steroid debate continues in the treatment of biliary atresia. CrossRefPubMed

19.

Willot S, Uhlen S, Michaud L, et al.: Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics. 2008;122(6):e1236–1241.CrossRefPubMed

20.

•• Kamath BM, Loomes KM, Piccoli DA: Medical management of Alagille syndrome. J. Pediatr. Gastroenterol. Nutr. 2010;50(6):580–586. This recently published review article provides an in-depth view of clinical evaluation and management of patients with Alagille syndrome. It focuses on management of the liver disease and the associated comorbidities in Alagille syndrome. CrossRefPubMed

21.

Emerick KM, Rand EB, Goldmuntz E, et al.: Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999;29(3):822–829.CrossRefPubMed

22.

Krantz ID, Piccoli DA, Spinner NB: Clinical and molecular genetics of Alagille syndrome. Curr. Opin. Pediatr. 1999;11(6):558–564.CrossRefPubMed

23.

Kamath BM, Bason L, Piccoli DA, et al.: Consequences of JAG1 mutations. J. Med. Genet. 2003;40(12):891–895.CrossRefPubMed

24.

•• Kaye AJ, Rand EB, Munoz PS, et al.: Effect of Kasai procedure on hepatic outcome in Alagille syndrome. J. Pediatr. Gastroenterol. Nutr. 2010;51(3):319–321. This retrospective review of the clinical database at Children's Hospital of Philadelphia evaluates 430 patients with a diagnosis of Alagille syndrome, focusing on outcomes of those patients who underwent hepatoportenterostomy (19) versus those who did not receive surgical intervention. PubMed

25.

Kamath BM, Schwarz KB, Hadzić N: Alagille syndrome and liver transplantation. J. Pediatr. Gastroenterol. Nutr. 2010;50(1):11–15.CrossRefPubMed

26.

Ling SC: Congenital cholestatic syndromes: what happens when children grow up? Can. J. Gastroenterol. 2007;21(11):743–751.PubMed

27.

Singhavejsakul J, Ukarapol N: Choledochal cysts in children: epidemiology and outcomes. World J Surg. 2008;32(7):1385–1388.CrossRefPubMed

28.

Singham J, Yoshida EM, Scudamore CH: Choledochal cysts: part 1 of 3: classification and pathogenesis. Can J Surg. 2009;52(5):434–440.PubMed

29.

•• Huang CS, Huang CC, Chen DF: Choledochal cysts: differences between pediatric and adult patients. J. Gastrointest. Surg. 2010;14(7):1105–1110. This study aims to differentiate clinical presentation and pathologic differences in children versus adults at the time of diagnosis of choledochal cyst disease. Although the classic presentation of jaundice, abdominal pain, and a palpable abdominal mass is described in many studies, this retrospective study finds that children tend to present with a palpable abdominal mass, whereas adults are more likely to present with abdominal pain and no palpable mass. Both groups were found to present with jaundice without any statistical difference. CrossRefPubMed

30.

Singham J, Yoshida EM, Scudamore CH: Choledochal cysts: part 2 of 3: Diagnosis. Can J Surg. 2009;52(6):506–511.PubMed

31.

Lipsett PA, Pitt HA: Surgical treatment of choledochal cysts. J Hepatobiliary Pancreat Surg. 2003;10(5):352–359.CrossRefPubMed

32.

Dabbas N, Davenport M: Congenital choledochal malformation: not just a problem for children. Ann R Coll Surg Engl. 2009;91(2):100–105.CrossRefPubMed

33.

Kim M, Han SJ, Yoon CS, et al.: Using MR cholangiopancreatography to reveal anomalous pancreaticobiliary ductal union in infants and children with choledochal cysts. AJR Am J Roentgenol. 2002;179(1):209–214.PubMed

34.

Park DH, Kim M, Lee SK, et al.: Can MRCP replace the diagnostic role of ERCP for patients with choledochal cysts? Gastrointest. Endosc. 2005;62(3):360–366.

35.

Tao K, Lu Y, Wang T, Dou K: Procedures for congenital choledochal cysts and curative effect analysis in adults. HBPD INT. 2002;1(3):442–445.PubMed

36.

Shi LB, Peng SY, Meng XK, et al.: Diagnosis and treatment of congenital choledochal cyst: 20 years' experience in China. World J. Gastroenterol. 2001;7(5):732–734.PubMed

37.

Shimotakahara A, Yamataka A, Yanai T, et al.: Roux-en-Y hepaticojejunostomy or hepaticoduodenostomy for biliary reconstruction during the surgical treatment of choledochal cyst: which is better? Pediatr. Surg. Int. 2005;21(1):5–7.CrossRefPubMed

38.

Watanabe Y, Toki A, Todani T: Bile duct cancer developed after cyst excision for choledochal cyst. J Hepatobiliary Pancreat Surg. 1999;6(3):207–212.CrossRefPubMed

39.

Miltenburg DM, Schaffer R, Breslin T, Brandt ML: Changing indications for pediatric cholecystectomy. Pediatrics. 2000;105(6):1250–1253.CrossRefPubMed

40.

Hofeldt M, Richmond B, Huffman K, et al.: Laparoscopic cholecystectomy for treatment of biliary dyskinesia is safe and effective in the pediatric population. Am Surg. 2008;74(11):1069–1072.PubMed

41.

Lugo-Vicente HL: Gallbladder dyskinesia in children. JSLS. 1997;1(1):61–64.PubMed

42.

Kaye AJ, Jatla M, Mattei P, et al.: Use of laparoscopic cholecystectomy for biliary dyskinesia in the child. J. Pediatr. Surg. 2008;43(6):1057–1059.CrossRefPubMed

43.

Punia R, Garg S, Bisht B, et al.: Clinico-pathological spectrum of gallbladder disease in children. Acta Paediatr. 2010.

44.

Chan S, Currie J, Malik AI, Mahomed AA: Paediatric cholecystectomy: Shifting goalposts in the laparoscopic era. Surg Endosc. 2008;22(5):1392–1395.CrossRefPubMed

45.

Bogue CO, Murphy AJ, Gerstle JT, et al.: Risk factors, complications, and outcomes of gallstones in children: a single-center review. J. Pediatr. Gastroenterol. Nutr. 2010;50(3):303–308.CrossRefPubMed

Titel: Biliary Disease in Children
verfasst von: Matthew Goldman
Thomas Pranikoff
Publikationsdatum: 01.04.2011
Verlag: Current Science Inc.
Erschienen in: Current Gastroenterology Reports / Ausgabe 2/2011
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI: https://doi.org/10.1007/s11894-010-0169-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Preoperative Stent Placement Versus Prompt Surgery for Cancer of the Head of the Pancreas

Gallbladder Dyskinesia: Fact or Fiction?

Diagnosis and Management of Acute Cholangitis

Clinical Trial Report: Endoscopic Treatment of Postoperative Bile Duct Strictures Using Multiple Stents: Long-Term Results

Complications of Endoscopic and Radiologic Investigation of Biliary Tract Disorders